As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: February 5, 2012
Alzheimer’s researchers create new antibody that enables detailed analysis of brain.
by Christopher Wright for Daily Rx
There is no cure for Alzheimer’s disease, and watching a loved one’s mental health degrade is an experience that no one should endure. Thankfully new research may lead to advancements in Alzeimer’s treatment.
A key distinctive sign of Alzheimer’s disease is the change in behavior of a protein called ‘tau.’ This protein is essential to neuron health and to the proper functioning of the brain.
Until recently this change has been a mystery but new antibody will allow for much deeper analysis of the tau protein. The study was led by Rakez Kayed, Ph.D., from the University of Texas Medical Branch at Galveston.
In a normal brain, the tau protein exists as an individual. However, in a brain of someone with Alzheimer’s, the tau protein forms twisted structures called ‘neurofibrillary tangles.’ Kayed discovered a new intermediate structure that is even more damaging than the tangles.
“What we discovered is that there are smaller structures that form before the neurofibrillary tangles, and they are much more toxic than the big structures, and we established that they were toxic in real human brains, which is important to developing an effective therapy,” said Kayed.
The researchers developed a new antibody, called T22, that only bonds with these intermediate structures, called tau oligomers. This allowed them to analyze the prevalence of the structures in healthy brains and those with Alzheimer’s.
The team found that tau oligomer levels were as much as four times higher than in a healthy brain of the same age.
“One thing that’s remarkable about this research is that before we developed this antibody, people couldn’t even see tau oligomers in the brain,” Kayed said. “With T22, we were able to thoroughly characterize them, and also study them in human brain cells.”
Picture Source: Today World News
White women whose genes put them at risk of developing Alzheimer’s disease are more likely than white men with similar risk genes to be diagnosed between the ages of 65 and 75, a study drawing on...
Researchers at the Keck School of Medicine of USC are tackling the sixth-leading cause of death in the United States—Alzheimer’s disease—with a new study that intervenes decades before the disease develops. The school is...
A devastating chronic neurodegenerative disease, Alzheimer’s disease (AD) currently affects around 5.5 million people in the United States alone. Causing progressive mental deterioration, it ultimately advances to impact basic bodily functions such as walking and...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.